These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 10072683)

  • 61. Early detection of mixed mutations selected by antiretroviral agents in HIV-infected primary human lymphocytes.
    Schinazi RF; Schlueter-Wirtz S; Stuyver L
    Antivir Chem Chemother; 2001; 12 Suppl 1():61-5. PubMed ID: 11594690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Synthesis and biological evaluation of alkenyldiarylmethane HIV-1 non-nucleoside reverse transcriptase inhibitors that possess increased hydrolytic stability.
    Cullen MD; Deng BL; Hartman TL; Watson KM; Buckheit RW; Pannecouque C; Clercq ED; Cushman M
    J Med Chem; 2007 Oct; 50(20):4854-67. PubMed ID: 17803290
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synthesis and studies of new 2-(coumarin-4-yloxy)-4,6-(substituted)-S-triazine derivatives as potential anti-HIV agents.
    Mahajan DH; Pannecouque C; De Clercq E; Chikhalia KH
    Arch Pharm (Weinheim); 2009 May; 342(5):281-90. PubMed ID: 19415671
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cellular pharmacology of D-d4FC, a nucleoside analogue active against drug-resistant HIV.
    Erickson-Viitanen S; Wu JT; Shi G; Unger S; King RW; Fish B; Klabe R; Geleziunas R; Gallagher K; Otto MJ; Schinazi RF
    Antivir Chem Chemother; 2003 Jan; 14(1):39-47. PubMed ID: 12790515
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Arylthiopyrrole (AThP) derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors: synthesis, structure-activity relationships, and docking studies (part 2).
    Lavecchia A; Costi R; Artico M; Miele G; Novellino E; Bergamini A; Crespan E; Maga G; Di Santo R
    ChemMedChem; 2006 Dec; 1(12):1379-90. PubMed ID: 17089434
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Design, synthesis and antiviral activity of novel 4,5-disubstituted 7-(beta-D-ribofuranosyl)pyrrolo[2,3-d][1,2,3]triazines and the novel 3-amino-5-methyl-1-(beta-D-ribofuranosyl)- and 3-amino-5-methyl-1-(2-deoxy-beta-D-ribofuranosyl)-1,5-dihydro-1,4,5,6,7,8-hexaazaacenaphthylene as analogues of triciribine.
    Migawa MT; Drach JC; Townsend LB
    J Med Chem; 2005 Jun; 48(11):3840-51. PubMed ID: 15916436
    [TBL] [Abstract][Full Text] [Related]  

  • 67. cycloSal-Pronucleotides of 2',3'-dideoxyadenosine and 2', 3'-dideoxy-2',3'-didehydroadenosine: synthesis and antiviral evaluation of a highly efficient nucleotide delivery system.
    Meier C; Knispel T; De Clercq E; Balzarini J
    J Med Chem; 1999 May; 42(9):1604-14. PubMed ID: 10229629
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies.
    Zhan P; Liu X; Li Z; Fang Z; Li Z; Wang D; Pannecouque C; Clercq ED
    Bioorg Med Chem; 2009 Aug; 17(16):5920-7. PubMed ID: 19620009
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pyrazole NNRTIs 1: design and initial optimisation of a novel template.
    Mowbray CE; Burt C; Corbau R; Perros M; Tran I; Stupple PA; Webster R; Wood A
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5599-602. PubMed ID: 19709880
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synthesis of novel diarylpyrimidine analogues and their antiviral activity against human immunodeficiency virus type 1.
    Guillemont J; Pasquier E; Palandjian P; Vernier D; Gaurrand S; Lewi PJ; Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers MH; Arnold E; Das K; Pauwels R; Andries K; de Béthune MP; Bettens E; Hertogs K; Wigerinck P; Timmerman P; Janssen PA
    J Med Chem; 2005 Mar; 48(6):2072-9. PubMed ID: 15771449
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Thiated derivatives of 2',3'-dideoxy-3'-fluorothymidine: synthesis, in vitro anti-HIV-1 activity and interaction with recombinant drug resistant HIV-1 reverse transcriptase forms.
    Miazga A; Hamy F; Louvel S; Klimkait T; Pietrusiewicz Z; Kurzyńska-Kokorniak A; Figlerowicz M; Wińska P; Kulikowski T
    Antiviral Res; 2011 Oct; 92(1):57-63. PubMed ID: 21683097
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Synthesis and biological evaluation of 6-substituted 5-alkyl-2-(phenylaminocarbonylmethylthio)pyrimidin-4(3H)-ones as potent HIV-1 NNRTIs.
    Yu M; Li Z; Liu S; Fan E; Pannecouque C; De Clercq E; Liu X
    ChemMedChem; 2011 May; 6(5):826-33. PubMed ID: 21322110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Synthesis and antiviral evaluation of 6-(trifluoromethylbenzyl) and 6-(fluorobenzyl) analogues of HIV drugs emivirine and GCA-186.
    El-Brollosy NR; Sørensen ER; Pedersen EB; Sanna G; La Colla P; Loddo R
    Arch Pharm (Weinheim); 2008 Jan; 341(1):9-19. PubMed ID: 18161905
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Synthesis and anti-HIV activity of GS-9148 (2'-Fd4AP), a novel nucleoside phosphonate HIV reverse transcriptase inhibitor.
    Boojamra CG; Mackman RL; Markevitch DY; Prasad V; Ray AS; Douglas J; Grant D; Kim CU; Cihlar T
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1120-3. PubMed ID: 18164198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Synthesis and biological evaluation of novel C5 halogen-functionalized S-DABO as potent HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Qin H; Liu C; Guo Y; Wang R; Zhang J; Ma L; Zhang Z; Wang X; Cui Y; Liu J
    Bioorg Med Chem; 2010 May; 18(9):3231-7. PubMed ID: 20371182
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Nucleosides and nucleotides. 158. 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)-cytosine, 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)uracil, and their nucleobase analogues as new potential multifunctional antitumor nucleosides with a broad spectrum of activity.
    Hattori H; Tanaka M; Fukushima M; Sasaki T; Matsuda A
    J Med Chem; 1996 Dec; 39(25):5005-11. PubMed ID: 8960561
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An approach towards the synthesis of potential metal-chelating TSAO-T derivatives as bidentate inhibitors of human immunodeficiency virus type 1 reverse transcriptase.
    Chamorro C; Camarasa MJ; Pérez-Pérez MJ; de Clercq E; Balzarini J; San Félix A
    Antivir Chem Chemother; 1998 Sep; 9(5):413-22. PubMed ID: 9875394
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
    ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives.
    Font M; Monge A; Alvarez E; Cuartero A; Losa MJ; Fidalgo MJ; SanMartín C; Nadal E; Ruiz I; Merino I; Martínez-Irujo JJ; Alberdi E; Santiago E; Prieto I; Lasarte JJ; Sarobe P; Borrás F
    Drug Des Discov; 1997 Apr; 14(4):305-32. PubMed ID: 9197981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.